>
pdufa.bio

CHS-1420

Updated ยทnext FDA decision on the calendar

CHS-1420 is a Coherus Oncology, Inc. program. Its next catalyst is a Readout in Sep 2027. Every date links its source.

CHRS catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Coherus Oncology, Inc. (CHRS). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Sep 2027CHRS

Questions

When is CHS-1420's next FDA decision or readout?

The next tracked catalyst for CHS-1420 is a Readout in Sep 2027.

What happened at CHS-1420's most recent FDA decision?

No FDA decision for CHS-1420 is in our archive yet.

Who makes CHS-1420?

Coherus Oncology, Inc. (CHRS).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.